Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

(2018) Kaitlyn K.H. Goey et al.   EUROPEAN JOURNAL OF CANCER

Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy

(2018) Reginald Anunobi et al.   JOURNAL OF SURGICAL RESEARCH

Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

(2018) Noomi Vainer et al.   Oncotarget

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cell‐Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta‐Analysis

(2017) Karen‐Lise G. Spindler et al.   ONCOLOGIST

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA

(2017) Andreas W. Berger et al.   PLoS One

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

(2016) S. El Messaoudi et al.   CLINICAL CANCER RESEARCH

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models

(2016) Victoria L Bridgeman et al.   JOURNAL OF PATHOLOGY

Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance

(2016) S. Nishimoto et al.   Science Advances

Colorectal Cancer Heterogeneity and Targeted Therapy: A Case for Molecular Disease Subtypes

(2015) J. F. Linnekamp et al.   CANCER RESEARCH

Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases

(2015) Han-Sin Jeong et al.   JNCI-Journal of the National Cancer Institute

Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases

(2015) Han-Sin Jeong et al.   JNCI-Journal of the National Cancer Institute

Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases

(2014) K. J. Roberts et al.   BRITISH JOURNAL OF SURGERY

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer

(2013) G J K Guthrie et al.   BRITISH JOURNAL OF CANCER

The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC

(2013) A D Nygaard et al.   BRITISH JOURNAL OF CANCER

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

(2012) Kjell Magne Tveit et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

(2011) C. Bokemeyer et al.   ANNALS OF ONCOLOGY

Circulating mitochondrial DAMPs cause inflammatory responses to injury

(2010) Qin Zhang et al.   NATURE

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

(2010) Alain R. Thierry et al.   NUCLEIC ACIDS RESEARCH